$NTHI 8-K SEC Filings

Filed On	Filing
22 Oct 2026	8-K: Regulation FD Disclosure NeOnc Technologies and the Department of Health – Abu Dhabi Sign MoU to Advance Brain Cancer Research and Proposed Clinical Collaboration
15 Oct 2026	8-K: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers; Regulation FD Disclosure With UAE authorizations for both lead drug candidates, NeOnc brings a clinical development perspective to discussions on capital, precision medicine and international collaboration
28 Sep 2026	8-K: Regulation FD Disclosure November 17 meeting will address Phase 2 study design and potential regulatory pathways
21 Sep 2026	8-K: Material Modifications to Rights of Security Holders; Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year +1 more NeOnc Technologies Redeems All Outstanding Series A Convertible Preferred Stock and Eliminates Related Potential Dilution
17 Sep 2026	8-K: Regulation FD Disclosure CEO Amir Heshmatpour has purchased 111,000 shares for approximately $418,700 since the Company announced positive NEO100 Phase 2a results
10 Sep 2026	8-K: Entry into a Material Definitive Agreement; Regulation FD Disclosure NeOnc Technologies Holdings, Inc. Announces Pricing of $15Million Registered Direct Offering Priced At-The-Market UnderNasdaq Rules with New and Existing Institutional Investors
20 Aug 2026	8-K: Submission of Matters to a Vote of Security Holders
13 Aug 2026	8-K: Regulation FD Disclosure
12 Aug 2026	8-K: Regulation FD Disclosure
10 Aug 2026	8-K: Results of Operations and Financial Condition; Regulation FD Disclosure
15 Jul 2026	8-K: Regulation FD Disclosure
02 Jul 2026	8-K: Departure/Election of Directors or Officers; Compensation
23 Jun 2026	8-K: Regulation FD Disclosure
18 Jun 2026	8-K: Regulation FD Disclosure
12 Jun 2026	8-K: Entry into a Material Definitive Agreement; Unregistered Sales of Equity Securities +2 more
18 May 2026	8-K: Results of Operations and Financial Condition; Regulation FD Disclosure
24 Apr 2026	8-K: Entry into a Material Definitive Agreement; Unregistered Sales of Equity Securities
16 Apr 2026	8-K: Regulation FD Disclosure
10 Apr 2026	8-K: Entry into a Material Definitive Agreement
03 Apr 2026	8-K: Results of Operations and Financial Condition; Regulation FD Disclosure

Comments